Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19
Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited. The study prospectively followed ...
Tag: Ritonavir
Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes
In a recent study published in the Canadian Medical Association Journal, researchers evaluated the effectiveness of nirmatrelvir–ritonavir in preventing coronavirus ...
New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems
In a recent study posted to the bioRxiv* preprint server, researchers at Emory University used severe acute respiratory syndrome coronavirus ...
What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?
In a recent study published in JAMA Network Open, researchers evaluated the incidence of coronavirus disease 2019 (COVID-19) rebound among ...
What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?
In a recent study published in JAMA Network Open, researchers examined the prevalence of contraindications to nirmatrelvir-ritonavir (Paxlovid) in hospitalized ...
What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?
In a recent article published in The Lancet, the authors commented on a recent observational study by Wong et al. ...
Impaired immune responses not responsible for COVID-19 rebound, findings suggest
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not ...
NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta
In a recent study posted to the bioRxiv* preprint server, researchers at the U.S National Institutes of Health demonstrated the efficacy of ...
Dolutegravir-based regimen more effective for treating pregnant people with HIV-1
Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in ...
The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19
In a recent study published in The Lancet, researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in ...
